References
- Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnosis criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
- Essah PA, Wickham EP, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. Clin Obstet Gynecol 2007;50:205–25
- Carmina E. Metabolic syndrome in polycystic ovary syndrome. Minerva Ginecol 2006;58:109–14
- Carmina E, Napoli N, Longo RA, et al. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol 2006;154:141–5
- Koroshi A. Microalbuminuria, is it so important? Hippokratia 2007;11:105–7
- Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004;110:32–5
- Patel AA, Bloomgarden ZT, Futterweit W. Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker. Endocr Pract 2008;14:193–200
- Abrahamson M, Olafsson I, Palsdottir A, et al. Structure and expression of the human cystatin C gene. Biochem J 1990;268:287–94
- Qing X, Furong W, Yunxia L, et al. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate. Cardiovasc Diabetol 2012;11:108. doi:10.1186/1475-2840-11-108
- Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981;140:815–30
- Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet 2005;366:1059–62
- Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007;92:399–404
- Dokras A, Bochner M, Hollinrake E, et al. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005;106:131–7
- Duleba AJ, Ahmed IM. Predictors of urinary albumin excretion in women with polycystic ovary syndrome. Fertil Steril 2010;93:2285–90
- Caglar GS, Oztas E, Karadag D, et al. The association of urinary albumin excretion and metabolic complications in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2011;154:57–61
- Caserta D, Adducchio G, Picchia S, et al. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. Gynecol Endocrinol 2014;30:397–402
- Carmina E. PCOS: metabolic impact and long-term management. Minerva Ginecol 2012;64:501–5
- Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health 2015;7:745–63
- Hyderali BN, Mala K. Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2015;191:15–22
- Magnusson M, Hedblad B, Engström G, et al. High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study. J Intern Med 2013;274:192–9
- Luo J, Wang LP, Hu HF, et al. Cystatin C and cardiovascular or all-cause mortality risk in the general population: a meta-analysis. Clin Chim Acta 2015;450:39–45